Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   In utero exposure to diethylstilbestrol and blood DNA methylation in adult women: Results from a meta-analysis of two cohort studies
  2. Bodelon, Clara; Gierach, Gretchen L; Hatch, Elizabeth E; Riseberg, Emily; Hutchinson,Amy; Yeager,Meredith; Sandler, Dale P; Taylor, Jack A; Hoover, Robert N; Xu, Zongli; Titus, Linda; Palmer, Julie R; Troisi, Rebecca
  3. Environmental Research. 2023, Aug 15; 231(Pt. 1): 115990.
  1. 2.   ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
  2. Schultz, Christopher W; Zhang, Yang; Elmeskini, Rajaa; Zimmermann, Astrid; Fu, Haiqing; Murai, Yasuhisa; Wangsa, Darawalee; Kumar, Suresh; Takahashi, Nobuyuki; Atkinson,Devon; Saha, Liton Kumar; Lee, Chien-Fei; Elenbaas, Brian; Desai, Parth; Sebastian, Robin; Sharma, Ajit Kumar; Abel, Melissa; Schroeder, Brett; Krishnamurthy, Manan; Kumar, Rajesh; Roper, Nitin; Aladjem, Mirit; Zenke, Frank T; Ohler,Zoe; Pommier, Yves; Thomas, Anish
  3. EMBO Molecular Medicine. 2023, Jul 25; e17313.
  1. 3.   Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins
  2. Szabova,Ludmila; Gordon, Melanie B; Lu, Lucy; Pate, Nathan; Bassel,Laura; Iacovelli, Anthony J; Karim,Baktiar; Homan, Philip J; Householder,Deborah; Guerin,Theresa; Burkett,Sandra; Day,Amanda; Custer Lawrence,Wendi; Ohler,Zoe
  3. Breast Cancer Research : BCR. 2022, Nov 04; 24(1): 75.
  1. 4.   Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
  2. Mavingire, Nicole; Campbell,Petreena; Wooten, Jonathan; Aja, Joyce; Davis, Melissa B.; Loaiza-Perez, Andrea; Brantley, Eileen
  3. CANCER LETTERS. 2021, Mar 1; 500: 64-74.
  1. 5.   Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors
  2. Tirosh, Amit; Mukherjee, Sanjit; Lack, Justin; Gara, Sudheer Kumar; Wang, Sophie; Quezado, Martha M; Keutgen, Xavier M; Wu, Xiaolin; Cam, Maggie; Kumar, Suresh; Patel, Dhaval; Nilubol, Naris; Tyagi, Monica Varun; Kebebew, Electron
  3. Cancer. 2019, Apr 15; 125(8): 1247-1257.
  1. 6.   Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection
  2. Shirey, Kari Ann; Sunday, Mary E.; Lai, Wendy; Patel, Mira C.; Blanco, Jorge C. G.; Cuttitta,Frank; Vogel, Stefanie N.
  3. Mucosal immunology. 2019, Jan; 12(1): 223-231.
  1. 7.   Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets
  2. Sandovici, I.; Smith, N. H.; Nitert, M. D.; Ackers-Johnson, M.; Uribe-Lewis, S.; Ito, Y.; Jones, R. H.; Marquez, V. E.; Cairns, W.; Tadayyon, M.; O'Neill, L. P.; Murrell, A.; Ling, C.; Constancia, M.; Ozanne, S. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Mar; 108(13): 5449-5454.
  1. 8.   Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas
  2. Chen, M.; Rahman, L.; Voeller, D.; Kastanos, E.; Yang, S. X.; Feigenbaum, L.; Allegra, C.; Kaye, F. J.; Steeg, P.; Zajac-Kaye, M.
  3. Oncogene. 2007, Jul; 26(33): 4817-4824.
  1. 9.   Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; An, P.; Kim, H. J.; Huang, J. Q.; Clarke, R.; Osborne, C. K.; Inman, J. K.; Appella, E.; Farrar, W. L.
  3. Cancer Cell. 2006, Dec; 10(6): 487-499.
  1. 10.   PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes
  2. Robinson-White, A. J.; Leitner, W. W.; Aleem, E.; Kaldis, P.; Bossis, I.; Stratakis, C. A.
  3. Cancer Research. 2006, Nov; 66(21): 10603-10612.
  1. 11.   Molecular alterations in primary prostate cancer after androgen ablation therapy
  2. Best, C. J. M.; Gillespie, J. W.; Yi, Y. J.; Chandramouli, G. V. R.; Perlmutter, M. A.; Gathright, Y.; Erickson, H. S.; Georgevich, L.; Tangrea, M. A.; Duray, P. H.; Gonzalez, S.; Velasco, A.; Linehan, W. M.; Matusik, R. J.; Price, D. K.; Figg, W. D.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Clinical Cancer Research. 2005, OCT 1; 11(19, Part 1): 6823-6834.
  1. 12.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
  1. 13.   Menin associates with a trithorax family histone methyltransferase complex and with the Hoxc8 locus
  2. Hughes, C. M.; Rozenblatt-Rosen, O.; Milne, T. A.; Copeland, T. D.; Levine, S. S.; Lee, J. C.; Hayes, D. N.; Shanmugam, K. S.; Bhattacharjee, A.; Biondi, C. A.; Kay, G. F.; Hayward, N. K.; Hess, J. L.; Meyerson, M.
  3. Molecular Cell. 2004 13(4): 587-597.
  1. 14.   Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee
  2. Shappell, S. B.; Thomas, G. V.; Roberts, R. L.; Herbert, R.; Ittmann, M. M.; Rubin, M. A.; Humphrey, P. A.; Sundberg, J. P.; Rozengurt, N.; Barrios, R.; Ward, J. M.; Cardiff, R. D.
  3. Cancer Research. 2004 64(6): 2270-2305.
  1. 15.   Effects of housing on the thymic deficiency in dwarf mice and its reversal by growth hormone administration
  2. Dorshkind, K.; Welniak, L.; Gault, R. A.; Hixon, J.; Montecino-Rodriguez, E.; Horseman, N. D.; Gertner, J. M.; Murphy, W. J.
  3. Clinical Immunology. 2003 109(2): 197-202.
  1. 16.   Of mice and MEN1: Insulinomas in a conditional mouse knockout
  2. Crabtree, J. S.; Scacheri, P. C.; Ward, J. M.; McNally, S. R.; Swain, G. P.; Montagna, C.; Hager, J. H.; Hanahan, D.; Edlund, H.; Magnuson, M. A.; Garrett-Beal, L.; Burns, A. L.; Ried, T.; Chandrasekharappa, S. C.; Marx, S. J.; Spiegel, A. M.; Collins, F. S.
  3. Molecular and Cellular Biology. 2003 23(17): 6075-6085.
  1. 17.   The role of growth hormone in T-cell development and reconstitution
  2. Welniak, L. A.; Sun, R.; Murphy, W. J.
  3. Journal of Leukocyte Biology. 2002 71(3): 381-387.
  1. 18.   Effects of prolactin on hematopoiesis
  2. Welniak, L. A.; Richards, S. M.; Murphy, W. J.
  3. Lupus. 2001 10(10): 700-705.
  1. 19.   Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel- Lindau patients
  2. Mohr, V. H.; Vortmeyer, A. O.; Zhuang, Z. P.; Libutti, S. K.; Walther, M. M.; Choyke, P. L.; Zbar, B.; Linehan, W. M.; Lubensky, I. A.
  3. American Journal of Pathology. 2000 157(5): 1615-1621.
  1. 20.   Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function
  2. Richards, S. M.; Murphy, W. J.
  3. Journal of Neuroimmunology. 2000 109(1): 56-62.
  1. 21.   Characterization of 3-epi-1 alpha,25-dihydroxyvitamin D-3 involved in 1 alpha,25-dihydroxyvitamin D-3 metabolic pathway in cultured cell lines
  2. Masuda, S.; Kamao, M.; Schroeder, N. J.; Makin, H. L. J.; Jones, G.; Kremer, R.; Rhim, J.; Okano, T.
  3. Biological & Pharmaceutical Bulletin. 2000 23(2): 133-139.
  1. 22.   Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine
  2. Woody, M. A.; Welniak, L. A.; Sun, R.; Tian, Z. G.; Henry, M.; Richards, S.; Raziuddin, A.; Longo, D. L.; Murphy, W. J.
  3. Experimental Hematology. 1999 27(5): 811-816.
  1. 23.   Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: Comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma
  2. Walther, M. M.; Reiter, R.; Keiser, H. R.; Choyke, P. L.; Venzon, D.; Hurley, K.; Gnarra, J. R.; Reynolds, J. C.; Glenn, G. M.; Zbar, B.; Linehan, W. M.
  3. Journal of Urology. 1999 162(3 Part 1): 659-664.
  1. 24.   Pilot Study of the Immunologic Effects of Recombinant Human Growth Hormone and Recombinant Insulin-Like Growth Factor in Hiv-Infected Patients
  2. Nguyen, B. Y.; Clerici, M.; Venzon, D. J.; Bauza, S.; Murphy, W. J.; Longo, D. L.; Baseler, M.; Gesundheit, N.; Broder, S.; Shearer, G.; Yarchoan, R.
  3. Aids. 1998 12(8): 895-904.
  1. 25.   Recombinant Human Growth Hormone Promotes Hematopoietic Reconstitution After Syngeneic Bone Marrow Transplantation in Mice
  2. Tian, Z. G.; Woody, M. A.; Sun, R.; Welniak, L. A.; Raziuddin, A.; Funakoshi, S.; Tsarfaty, G.; Longo, D. L.; Murphy, W. J.
  3. Stem Cells. 1998 16(3): 193-199.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel